Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesCost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States
British Medical Journal, 10/22/09
Kim JJ et al. – Given currently available information, including boys in an HPV vaccination programme generally exceeds conventional thresholds of good value for money, even under favourable conditions of vaccine protection and health benefits. Uncertainty still exists in many areas that can either strengthen or attenuate these findings. As new information emerges, assumptions and analyses will need to be iteratively revised to continue to inform policies for HPV vaccination.
Related Articles
Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States
Annals of Internal Medicine, 10/21/09
Relevance Score: 94%
ACIP Supports 'Permissive Use,' But Not Routine Use, of Gardasil in Males
American Family Physician, 10/29/09
Relevance Score: 90%
Adoption of Rotavirus Vaccination by Pediatricians and Family Medicine Physicians in the United States
Pediatrics, 10/28/09
Relevance Score: 90%
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09
Relevance Score: 90%
A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
British Journal of Cancer, 10/09/09
Relevance Score: 90%
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
DNA vaccines for biodefense
Expert Review of Vaccines, 12/08/09
Prospects for new plague vaccines
Expert Review of Vaccines, 12/08/09
Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines
Expert Review of Vaccines, 12/08/09
Article Search
Sponsor